Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported Outcomes

Clinical trial NCT04319237 · COMPLETED

Trial details

NCT number: NCT04319237
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: COMPLETED
Study type: OBSERVATIONAL

Diffuse Large B Cell Lymphoma Transformed Lymphoma

Start date: 2020-03-10
Primary completion: 2023-07-14
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.